Trends in intravenous iron use among dialysis patients in the United States (1994-2002)

American Journal of Kidney Diseases

Volumn 46, Issue 4, 2005, Pages 650-660

  St Peter, Wendy L ^a   Obrador, Gregorio T ^b   Roberts, Tricia L ^b   Collins, Allan J ^b  

^a US Renal Data System   (United States)

^b NONE

Author keywords

Anemia; Dialysis; Erythropoietin; Ferric gluconate; Hematocrit; Intravenous iron; Iron dextran; Iron sucrose

Indexed keywords

FERRIC GLUCONATE; FERRIC HYDROXIDE SUCROSE; HEMOGLOBIN; IRON; IRON DEXTRAN; RECOMBINANT ERYTHROPOIETIN;

ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; COHORT ANALYSIS; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; DIALYSIS; DOSE RESPONSE; DRUG USE; FEMALE; HEMODIALYSIS PATIENT; HUMAN; INCIDENCE; INFANT; MALE; MEDICAL RECORD; MEDICARE; NEWBORN; OUTPATIENT; PERITONEAL DIALYSIS; PREVALENCE; UNITED STATES;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANEMIA, HYPOCHROMIC; CHILD; CHILD, PRESCHOOL; DRUG UTILIZATION; ERYTHROPOIETIN, RECOMBINANT; FEMALE; FERRIC COMPOUNDS; HUMANS; INCIDENCE; INFANT; INFUSIONS, INTRAVENOUS; KIDNEY FAILURE, CHRONIC; MALE; MEDICARE; MIDDLE AGED; OUTPATIENTS; PERITONEAL DIALYSIS; PREVALENCE; RENAL DIALYSIS; RETROSPECTIVE STUDIES; UNITED STATES;

EID: 25644432169     PISSN: 02726386     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.ajkd.2005.06.018     Document Type: Article

References (26)

1. National Kidney Foundation K/DOQI Clinical Practice Guidelines for Anemia of Chronic Kidney Disease Update 2000 Am J Kidney Dis 37 suppl 1 2001 S182 S238
2. US Renal Data System USRDS 2004 Annual Data Report 2004 The National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases Bethesda, MD
3. A. Besarab, S. Frinak, J. Yee An indistinct balance The safety and efficacy of parenteral iron therapy J Am Soc Nephrol 10 1999 2029 2043
4. J.W. Eschbach, J.D. Cook, B.H. Scribner, C.A. Finch Iron balance in hemodialysis patients Ann Intern Med 87 1977 710 713
5. M. Mungiole, L.W. Pickle, K.H. Simonson Application of a weighted head-banging algorithm to mortality data maps Stat Med 18 1999 3201 3209
6. S. Fishbane, E.A. Kowalski The comparative safety of intravenous iron dextran, iron saccharate, and sodium ferric gluconate Semin Dial 13 2000 381 384
7. Centers for Medicare & Medicaid Services End-Stage Renal Disease (ESRD) Program ESRD Clinical Performance Measures (CPMs) Project 2004 Department of Health and Human Services, Centers for Medicare & Medicaid Services, Center for Beneficiary Choices Baltimore, MD
8. NKF DOQI Clinical Practice Guidelines for the Treatment of Anemia of Chronic Renal Failure Am J Kidney Dis 30 suppl 3 1997 S192 S237
9. S.M. Payne Iron and virulence in the family Enterobacteriaceae Crit Rev Microbiol 16 1988 81 111
10. M.L. Guerinot Microbial iron transport Annu Rev Microbiol 48 1994 743 772
11. S.I. Patruta, R. Edlinger, G. Sunder-Plassmann, W.H. Horl Neutrophil impairment associated with iron therapy in hemodialysis patients with functional iron deficiency J Am Soc Nephrol 9 1998 655 663
12. P.S. Lim, Y.H. Wei, Y.L. Yu, B. Kho Enhanced oxidative stress in haemodialysis patients receiving intravenous iron therapy Nephrol Dial Transplant 14 1999 2680 2687
13. D. Tovbin, D. Mazor, M. Vorobiov, C. Chaimovitz, N. Meyerstein Induction of protein oxidation by intravenous iron in hemodialysis patients Role of inflammation Am J Kidney Dis 40 2002 1005 1012
14. R.A. Zager, A.C. Johnson, S.Y. Hanson, H. Wasse Parenteral iron formulations A comparative toxicologic analysis and mechanisms of cell injury Am J Kidney Dis 40 2002 90 103
15. H.I. Feldman, J. Santanna, W. Guo Iron administration and clinical outcomes in hemodialysis patients J Am Soc Nephrol 13 2002 734 744
16. H.I. Feldman, M. Joffe, B. Robinson Administration of parenteral iron and mortality among hemodialysis patients J Am Soc Nephrol 15 2004 1623 1632
17. W.L. St Peter, T.L. Roberts, A.J. Collins Racial differences in hematocrit levels and erythropoietin doses J Am Soc Nephrol 12 2001 248A (abstr)
18. US Renal Data System USRDS 2001 Annual Data Report 2001 The National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases Bethesda, MD
19. Centers for Medicare & Medicaid Services 2003 Annual Report, End-Stage Renal Disease Clinical Performance Measures Project 2003 Department of Health and Human Services, Centers for Medicare & Medicaid Services, Center for Beneficiary Choices Baltimore, MD
20. R.L. Wingard, R.A. Parker, N. Ismail, R.M. Hakim Efficacy of oral iron therapy in patients receiving recombinant human erythropoietin Am J Kidney Dis 25 1995 433 439
21. G.T. Obrador, T. Roberts, W.L. St Peter, E. Frazier, B.J. Pereira, A.J. Collins Trends in anemia at initiation of dialysis in the United States Kidney Int 60 2001 1875 1884
22. D.J. Cotter, M. Thamer, P.L. Kimmel, J.H. Sadler Secular trends in recombinant erythropoietin therapy among the U.S. hemodialysis population 1990-1996 Kidney Int 54 1998 2129 2139
23. Centers for Medicare & Medicaid Services 2001 Annual Report, End-Stage Renal Disease Clinical Performance Measures Project. 1-106 2001 Department of Health and Human Services, Centers for Medicare & Medicaid Services, Center for Beneficiary Choices Baltimore, MD
24. J.A. Coladonato, D.L. Frankenfield, D.N. Reddan Trends in anemia management among US hemodialysis patients J Am Soc Nephrol 13 2002 1288 1295
25. D. Frankenfield, C.A. Johnson, J.B. Wish, M.V. Rocco, F. Madore, W.F. Owen Anemia management of adult hemodialysis patients in the US Results from the 1997 ESRD Core Indicators Project Kidney Int 57 2000 578 589
26. I.C. Macdougall Strategies for iron supplementation Oral versus intravenous Kidney Int Suppl 69 1999 S61 S66